Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

IMaging and Physiologic Predictors of Atherosclerotic Progression in Deferred Lesions With Contemporary Medical Treatment Based on Fractional Flow Reserve-guided Strategy

NCT03030495 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT03030495
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03030495 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
IMaging and Physiologic Predictors of Atherosclerotic Progression in Deferred Lesions With Contemporary Medical Treatment Based on Fractional Flow Reserve-guided Strategy
Lead sponsor
Samsung Medical Center
Phase
Observational
Overall status
Active, not recruiting
Start date
December 1, 2016
Completion date
December 31, 2025
Enrollment
1,400 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

ischemic heart disease